MARKET WIRE NEWS

GE HealthCare builds on BARDA collaboration with approximately $35 million expansion to advance artificial intelligence-powered ultrasound for trauma care and emergency preparedness

MWN-AI** Summary

GE HealthCare has announced a significant expansion of about $35 million to an existing collaboration with the Biomedical Advanced Research and Development Authority (BARDA). This partnership, part of the U.S. Department of Health and Human Services, aims to advance artificial intelligence (AI)-powered ultrasound technology, particularly for trauma care and emergency preparedness. The funding will primarily come from BARDA, reinforcing their commitment to improve healthcare solutions for mass casualty incidents.

Philip Rackliffe, President and CEO of GE HealthCare's Advanced Visualization Solutions, emphasized the critical need for rapid and accurate medical responses in emergencies. The expanded agreement builds upon a program introduced in October 2023 and focuses on developing innovative ultrasound solutions that enhance the diagnostic capabilities of healthcare providers, especially in high-pressure settings like emergency departments and field hospitals.

One of the key goals of this project is to create new AI-driven tools that enable quicker diagnostics and reduce reliance on expert operators, making ultrasound more accessible even for non-specialists. The initiative aims to refine the detection of lung and intra-abdominal injuries, which are vital in trauma care. Additionally, it will develop point-of-care ultrasound solutions that can perform reliably in challenging environments.

The expansion also includes efforts to engage with frontline clinicians and medical sites to gather real-world insights, ensuring the developed technologies meet practical needs. GE HealthCare's commitment to innovating emergency medical solutions reflects its long history in ultrasound technology and aims to positively impact patient outcomes during critical situations.

This initiative highlights GE HealthCare's dedication to transforming the healthcare landscape and improving the tools available to clinicians, marking an important step toward more efficient and effective trauma care.

MWN-AI** Analysis

GE HealthCare (Nasdaq: GEHC) has made a significant move by expanding its partnership with the Biomedical Advanced Research and Development Authority (BARDA) through a $35 million investment to advance its AI-powered ultrasound technologies for trauma and emergency preparedness. This collaboration, which is primarily funded by BARDA, underscores the strategic importance of innovative medical solutions in high-pressure environments.

The new AI tools being developed are designed to streamline diagnostics, reducing dependency on expert operators, which is essential in emergency settings. Enhanced capabilities for assessing lung pathologies and intra-abdominal injuries can potentially lead to quicker and more accurate medical responses during mass casualty incidents, thereby improving patient outcomes.

This advancement positions GE HealthCare as a leader in emergency medicine and could significantly increase its market share in the medical technology sector, particularly in trauma care. Investors should take note of the potential for high demand in point-of-care solutions as hospitals and emergency facilities increasingly adopt advanced technologies to optimize patient care.

Furthermore, GE HealthCare’s commitment to engaging directly with clinicians and medical evaluation sites is a smart strategy. This engagement not only helps refine their offerings based on real-world feedback but also facilitates broader acceptance and adoption across various healthcare systems. As hospitals seek to enhance operational efficiencies and patient outcomes, GE HealthCare’s innovations could see accelerated uptake.

Considering the ongoing shift towards AI and tech-driven solutions in healthcare, GE HealthCare's recent activities present a favorable outlook for long-term growth. Investors looking for opportunities in the healthcare sector may find GEHC's focus on AI-driven technologies particularly appealing. As healthcare continues to evolve, companies like GE HealthCare that leverage cutting-edge technology will likely be at the forefront, making them worthy of close attention.

**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.

Source: Business Wire

GE HealthCare (Nasdaq: GEHC) today announced a new approximately $35 million expansion to a previous contract with the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response (ASPR) within the U.S. Department of Health and Human Services (HHS). The expansion is structured as a cost-share between BARDA and GE HealthCare, with BARDA providing the majority of funding. This jointly funded expanded agreement builds on the existing program announced in October 2023 and reflects continued momentum to develop artificial intelligence (AI)-powered ultrasound solutions and new platforms to support trauma assessment and preparedness for mass casualty incidents.

“Responding to a mass casualty incident demands speed, precision and access to care, especially in high-pressure environments like emergency departments, field hospitals, and medical transport,” said Philip Rackliffe, President and CEO, Advanced Visualization Solutions, GE HealthCare. “Our strategic alignment with BARDA enables us to continue to drive ultrasound innovation through advanced AI tools and specialized hardware designed for the front lines of care.”

The expanded clinical scope of the agreement will facilitate development of several new AI-powered tools designed to enhance diagnostic speed and reduce operator dependency, even for non-expert ultrasound users. These new automated capabilities will be designed to support more detailed assessments of lung pathologies, including pleural pathologies, and improve detection of intra-abdominal injuries. In addition, GE HealthCare will create point-of-care ultrasound solutions designed to improve reliability and usability in demanding environments, including field-based care settings.

“GE HealthCare has long been at the forefront of ultrasound innovation in emergency medicine, especially at the point-of-care,” said Karley Yoder, CEO, Comprehensive Care Ultrasound, Advanced Visualization Solutions, GE HealthCare. “This milestone reflects our shared aspiration to equip clinicians with tools that enhance decision-making and help improve patient outcomes in even the most challenging scenarios.”

In addition to further technology development, the expanded program also enables new efforts to engage with clinicians and medical evaluation sites. These activities will help generate clinical evidence, inform ongoing development, and ensure the technology is shaped by real-world feedback. By working directly with experts in emergency medicine, GE HealthCare aims to validate the impact of these innovations and support broader adoption across diverse healthcare environments.

This project is supported in part with federal funds from the U.S. Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract number 75A50123C00035.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Imaging, Advanced Visualization Solutions, Patient Care Solutions, and Pharmaceutical Diagnostics segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn , Facebook , Instagram , or visit our website for our latest news and perspectives .

View source version on businesswire.com: https://www.businesswire.com/news/home/20260217636198/en/

GE HealthCare Media Contact:
Eric Tatro
M +1 312 459-6140
eric.tatro@gehealthcare.com

FAQ**

How will the $35 million expansion of the BARDA contract impact GE HealthCare Technologies Inc. GEHC's overall growth strategy in the AI ultrasound market?

The $35 million BARDA contract expansion is likely to accelerate GE HealthCare Technologies Inc.'s growth strategy in the AI ultrasound market by enhancing its research and development capabilities, enabling the company to deliver advanced imaging solutions and strengthen its competitive position.

In what ways does GE HealthCare Technologies Inc. GEHC plan to enhance its AI-powered tools to ensure usability for non-expert ultrasound users?

GE HealthCare Technologies Inc. plans to enhance its AI-powered tools for non-expert ultrasound users by focusing on intuitive interfaces, streamlined workflows, and comprehensive training resources to improve accessibility and user confidence in performing ultrasound examinations.

What specific outcomes does GE HealthCare Technologies Inc. GEHC expect from engaging with clinicians and medical evaluation sites during the new program?

GE HealthCare Technologies Inc. expects to enhance product development, improve clinical workflows, and gather actionable insights to optimize patient care through collaborative engagement with clinicians and medical evaluation sites in their new program.

How does the partnership with BARDA align with GE HealthCare Technologies Inc. GEHC's long-term objectives in emergency medicine and trauma care innovation?

The partnership with BARDA aligns with GE HealthCare's long-term objectives by enhancing innovation in emergency medicine and trauma care, facilitating the development of advanced medical technologies and solutions that improve patient outcomes in critical situations.

**MWN-AI FAQ is based on asking OpenAI questions about GE HealthCare Technologies Inc. (NASDAQ: GEHC).

GE HealthCare Technologies Inc.

NASDAQ: GEHC

GEHC Trading

-0.71% G/L:

$74.63 Last:

775,232 Volume:

$73.35 Open:

mwn-ir Ad 300

GEHC Latest News

GEHC Stock Data

$36,104,496,542
451,192,269
0.09%
690
N/A
Medical Diagnostics & Screening
Healthcare
US
Chicago

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App